Subsequent Events |
6 Months Ended |
|---|---|
Jun. 30, 2026 | |
| Subsequent Events [Abstract] | |
| Subsequent Events | 17. Subsequent Events
Subsequent to June 30, 2026, we acquired a business and signed a merger agreement with a separate privately held company that is expected to close once regulatory approval is received. The initial cash consideration for these acquisitions is approximately $245 million with additional contingent consideration of up to $210 million if certain regulatory and revenue milestones are achieved. These acquisitions provide us new pain management technology that can be used in procedures across multiple product categories and surgical technology to expand our product portfolio. We are in the process of determining fair values of assets acquired and liabilities assumed. |